Related Experiment Video
Updated: Jun 15, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic
Philipp Ivanyi1, Michael Morgan, Wenji Piao
1Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Medizinische Hochschule Hannover, Hannover, Germany.
The T-cell receptor alpha/preTCR (pTalpha) impacts T-cell leukemia (T-ALL) proliferation. Inhibiting the src-kinase p56(Lck) with PP1 reduced T-ALL cell survival, suggesting p56(Lck) as a therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- The pTalpha/preTCR complex is vital for T-cell development, regulating beta-selection and thymocyte survival via p56(Lck).
- Aberrant pTalpha expression is implicated in T-cell lymphoblastic leukemia (T-ALL).
Purpose of the Study:
- To investigate the role of pTalpha and p56(Lck) in human T-ALL.
- To evaluate the therapeutic potential of targeting p56(Lck) in T-ALL.
Main Methods:
- Analysis of pTalpha and p56(Lck) mRNA and protein expression in T-ALL cell lines.
- Assessment of tyrosine-phosphorylation levels.
- Growth inhibition assays using the p56(Lck) inhibitor PP1.
- Cell cycle and apoptosis analyses.
Main Results:
- pTalpha expression differed in T-ALL cell lines compared to normal counterparts.
- PP1 treatment inhibited growth in 6/11 T-ALL cell lines, causing G(1/0) cell cycle arrest or apoptosis.
- PP1-sensitive T-ALL cells expressed p56(Lck) and showed elevated tyrosine-phosphorylation.
Conclusions:
- pTalpha-mediated proliferation is significant in thymic T-ALL.
- p56(Lck) is a potential therapeutic target for T-ALL and other lymphoid malignancies, independent of pTalpha.
More Related Videos
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
07:17Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024